New treatment for kala azar, the most deadly parasitic disease after malaria

East Africa is fighting the worst kala-azar outbreak in a decade. Collaboration across the region through LEAP has resulted in the development of a new, cheaper combination therapy, nearly halving the treatment length (30 days to 17). East African endemic countries are taking the necessary regulatory measures to use it in their programs, but experts warn that without international funding or interest in supporting governments in the roll out, too few patients will benefit.

Read the whole article on Science Daily

More from Science Daily